San Francisco, United States
ClinCapture, established in 2013, is on a mission to build Software that Saves Lives®. By leveraging its unique Virtual Data Capture® (VDC®) technology, the company is transforming how clinical trials are conducted. As the only provider of VDC®, ClinCapture offers a suite of cutting-edge products that facilitate remote and decentralized clinical trials, thus having a substantial impact on the biotechnology and pharmaceutical landscape.
Headquartered in the United States, ClinCapture operates across several industries, including Biotechnology, Enterprise Software, Medical Devices, and Pharmaceuticals. Their innovative eClinical solutions help sponsors and CROs reduce costs and expedite processes, crucial for the evaluation of new medicines.
The company last received a Seed Round investment on 02 January 2018, backed by investors Healthy Ventures and Rock Health Capital. Ideal for potential investors seeking to engage in disruptive and progressive biotech solutions, ClinCapture positions itself as a driving force in the acceleration of clinical trials.
